IgA nephropathy: Difference between revisions
Jump to navigation
Jump to search
Line 41: | Line 41: | ||
== Diagnosis == | == Diagnosis == | ||
[[IgA nephropathy history and symptoms|History and Symptoms]] | [[IgA nephropathy physical examination|Physical Examination]] | [[IgA nephropathy laboratory findings|Laboratory Findings | [[IgA nephropathy history and symptoms|History and Symptoms]] | [[IgA nephropathy physical examination|Physical Examination]] | [[IgA nephropathy laboratory findings|Laboratory Findings]] | [[IgA nephropathy CT|CT]] | [[IgA nephropathy MRI|MRI]] | [[IgA nephropathy echocardiography or ultrasound|Echocardiography or Ultrasound]] | [[IgA nephropathy other diagnostic studies|Other Diagnostic Studies]] | ||
== Treatment == | == Treatment == |
Revision as of 18:53, 30 September 2012
For patient information click here Template:DiseaseDisorder infobox
IgA nephropathy Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
IgA nephropathy On the Web |
American Roentgen Ray Society Images of IgA nephropathy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]
Synonyms and keywords: IgA nephritis; IgAN; Berger's disease; synpharyngitic glomerulonephritis
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating IgA nephropathy from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | CT | MRI | Echocardiography or Ultrasound | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies